Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|November 19, 2021
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samplesRuben Van Paemel, Charlotte Vandeputte, Lennart Raman, et al.
Cancer Discovery|March 16, 2022
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent MalignanciesPablo Berlanga, Gaelle Pierron, Ludovic Lacroix, et al.
Circulation|January 8, 2024
A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory NetworkMichael T Broman, Rangarajan D Nadadur, Carlos Perez-Cervantes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted TherapyCharles Bobin, Yasmine Iddir, Charlotte Butterworth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical ModelsElizabeth R Tucker, Irene Jiménez, Lindi Chen, et al.
JCO Precision Oncology|October 20, 2022
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility StudyOlivia Ruhen, Nathalie S M Lak, Janine Stutterheim, et al.
Physical Review Letters|September 10, 2025
Probing Benchmark Models of Hidden-Sector Dark Matter with DAMIC-MK Aggarwal, I Arnquist, N Avalos, et al.
Physical Review Letters|March 22, 2024
Search for Daily Modulation of MeV Dark Matter Signals with DAMIC-MI Arnquist, N Avalos, D Baxter, et al.
Physical Review Letters|May 12, 2023
First Constraints from DAMIC-M on Sub-GeV Dark-Matter Particles Interacting with ElectronsI Arnquist, N Avalos, D Baxter, et al.
NPJ Precision Oncology|January 10, 2026
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncologyMarlinde C Schoonbeek, Pierre Gestraud, Lindy Vernooij, et al.
Pageof 8